STOCK TITAN

Cue Health Inc. - HLTH STOCK NEWS

Welcome to our dedicated page for Cue Health news (Ticker: HLTH), a resource for investors and traders seeking the latest updates and insights on Cue Health stock.

Cue Health Inc. (HLTH) is a pioneering healthcare technology company that empowers individuals to manage their health with precision and convenience. Cue Health offers a revolutionary device that tracks key health and lifestyle indicators at the molecular level, including inflammation, vitamin D, fertility, influenza, and testosterone. This compact, user-friendly device enables consumers to perform these tests at home in just minutes.

The data collected by Cue is sent via Bluetooth 4.0 to the user’s smartphone, where the free Cue app provides an in-depth analysis of how activity, food, and sleep impact their health. By using noninvasive samples such as saliva, blood, or nasal swabs, users can access lab-quality information about their bodies on demand.

Recent Achievements:

  • The company has gained recognition for its innovative approach to personal health monitoring, making previously lab-exclusive data accessible to the general public.
  • Partnerships with leading healthcare providers have expanded the usability and integration of Cue devices.

Current Projects:

  • Continued development of advanced features within the Cue app, including interactive charts that help users visualize their health trends.
  • Research-based recommendations for foods proven to support optimal health tailored to the user's specific molecular data.

By offering a comprehensive tool for health management, Cue Health Inc. continues to play a significant role in transforming how individuals monitor and improve their well-being. The company’s dedication to providing accessible and real-time health data is a testament to its commitment to innovation and public health.

Rhea-AI Summary

Cue Health Inc. (Nasdaq: HLTH) announced a collaboration with Fresenius Kidney Care on August 24, 2022, to deliver accurate COVID-19 self-testing for immunocompromised patients across several locations, including Hawaii and Puerto Rico. The initiative focuses on early detection to prevent complications and hospitalizations, particularly in remote areas. The Cue Health Monitoring System will be utilized for both in-center and at-home testing. This partnership aims to enhance patient access to timely diagnostics while ensuring confidence in testing accuracy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
none
-
Rhea-AI Summary

Cue Health Inc. (Nasdaq: HLTH) announced the results of the largest clinical study on asymptomatic individuals, showing its COVID-19 test achieved a 99.4% accuracy compared to lab-based PCR tests. The study analyzed 3,037 samples, reporting 100% clinical sensitivity with no false negatives. Conducted at FH Health in Ontario, Canada, it highlights the test's rapid results (approximately 20 minutes) and potential to facilitate timely treatment while maintaining cost-effectiveness. The test is FDA authorized for professional and home use.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.74%
Tags
covid-19
-
Rhea-AI Summary

Cue Health Inc. (Nasdaq: HLTH) reported strong financial results for Q2 2022, boasting revenue of $87.7 million, surpassing expectations due to heightened COVID-19 test orders. The company shipped over 250,000 Cue Readers and is progressing with FDA submissions for flu and multiplex studies. Cue Health ended the quarter with $363.1 million in cash, while also initiating a $100 million secured credit facility. GAAP net income reflected a loss of $99.1 million primarily due to restructuring costs and elevated operating expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.79%
Tags
none
Rhea-AI Summary

Cue Health (NASDAQ: HLTH), a leader in healthcare technology, announced its participation in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 16, 2022. Cue Health provides individuals with easy access to health information and diagnostics, enabling effective health management. The company is recognized for its FDA-authorized at-home COVID-19 test and has received various international approvals, including CE mark in the EU and authorization from Health Canada and India. Founded in 2010, Cue is headquartered in San Diego.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.46%
Tags
conferences
-
Rhea-AI Summary

Cue Health Inc. (NASDAQ: HLTH) is set to release its Q2 2022 financial results on August 10, 2022, at 1:30 p.m. PT. A conference call will be held to discuss these results and recent developments. Interested participants can register in advance to access the call and receive a unique PIN. Cue Health, established in 2010 and headquartered in San Diego, specializes in healthcare technology with a focus on providing accessible, lab-quality diagnostics. The company is known for its FDA-authorized at-home COVID-19 test.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
-
Rhea-AI Summary

Cue Health Inc. (Nasdaq: HLTH) announced the appointment of Allison Blackwell as Chief Human Resources Officer. With over 20 years in the healthcare sector, Blackwell previously held leadership roles at Danaher Corporation and Beckman Coulter. Her expertise includes human resources, diversity and inclusion, and employee relations. Blackwell aims to enhance Cue's HR strategies to support company objectives. CEO Ayub Khattak expressed confidence in her leadership to further Cue's mission of innovating healthcare delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.25%
Tags
management
Rhea-AI Summary

Cue Health (NASDAQ: HLTH), a healthcare technology company, has announced its management team's participation in two upcoming conferences. The first is the 43rd Annual Goldman Sachs Global Healthcare Conference on June 15, 2022, at 6:20 p.m. Eastern Time, held at the Terranea Resort, Rancho Palos Verdes. The second event is the 7th Annual Cowen FutureHealth Conference on June 22, 2022, at 1:35 p.m. Eastern Time. For further details and access to the presentations, visit www.cuehealth.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.02%
Tags
conferences
-
Rhea-AI Summary

Cue Health Inc. (Nasdaq: HLTH) reported its first quarter 2022 financial results, achieving $179.4 million in revenue, up from $64.5 million in Q1 2021, marking a 178% year-over-year growth. This increase was driven by expanding the customer base and production capacity. Private sector revenue constituted 98% of total revenue. However, operating expenses rose significantly to $89.9 million, impacting net income which fell to $2.8 million from $13 million in the previous year. Cue also projects Q2 2022 revenues between $50 million and $55 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.46%
Tags
none
-
Rhea-AI Summary

Cue Health (Nasdaq: HLTH) submitted a request for full FDA clearance of its molecular COVID-19 test for at-home use, marking a significant milestone in home testing technology. The test previously received Emergency Use Authorization, demonstrating a high accuracy rate of 98.9%. Cue's COVID-19 test has been utilized by major healthcare institutions and organizations, further validating its reliability. The company aims to expand its molecular testing capabilities to address various health conditions, making healthcare more accessible and effective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.48%
Tags
covid-19
Rhea-AI Summary

Cue Health (NASDAQ: HLTH) is set to release its Q1 2022 financial results on May 11, 2022, at 1:30 PM PT / 4:30 PM ET. The company will host a conference call to discuss its financial performance and recent highlights. Interested participants can join the call by dialing (888) 708-0136 domestically or (929) 517-9009 internationally, using conference ID: 9165254. A live webinar will be available on the company's investor website, with a replay accessible shortly after the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.16%
Tags

FAQ

What is the current stock price of Cue Health (HLTH)?

The current stock price of Cue Health (HLTH) is $0.0434 as of June 5, 2024.

What is the market cap of Cue Health (HLTH)?

The market cap of Cue Health (HLTH) is approximately 6.9M.

What does Cue Health Inc. specialize in?

Cue Health Inc. specializes in providing a device that tracks key health and lifestyle indicators at the molecular level, enabling at-home testing and real-time health data analysis.

How does Cue's device work?

The device uses noninvasive samples such as saliva, blood, or nasal swabs to measure health indicators and sends the data via Bluetooth to the user’s smartphone for analysis.

What health indicators can Cue track?

Cue can track inflammation, vitamin D, fertility, influenza, and testosterone levels in just minutes at home.

What is the Cue app?

The Cue app is a free application that receives data from the Cue device and provides detailed insights into how activity, food, and sleep affect your health.

What recent achievements has Cue Health made?

Cue Health has been recognized for making lab-quality health data accessible at home and has formed partnerships with leading healthcare providers to enhance device usability.

What are some current projects at Cue Health?

Current projects include developing advanced app features like interactive health charts and offering personalized, research-based health recommendations.

How does Cue Health send data to a user's smartphone?

Cue Health uses Bluetooth 4.0 technology to send health data from the device to the user's smartphone.

Can the Cue device track trends in personal health?

Yes, the Cue app provides interactive charts that allow users to monitor their health trends over time and discover new patterns.

Is Cue Health's testing method invasive?

No, Cue Health uses noninvasive methods such as saliva, blood, or nasal swabs to collect health data.

What makes Cue Health unique?

Cue Health is unique in its ability to provide immediate, lab-quality health data at home, enabling users to make informed health decisions in real-time.

Cue Health Inc.

Nasdaq:HLTH

HLTH Rankings

HLTH Stock Data

6.90M
159.09M
11.57%
52.81%
0.49%
Health Information Services
Laboratory Analytical Instruments
Link
United States of America
SAN DIEGO